"Supply constraints" prevented adequate stock, according to the society's notice ... In response to the letter, Mylan said that the FDA warning did not "affect Pfizer's ability to manufacture and supply" products from the facility.
Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views. (Sharecast News) - American speciality pharmaceuticals company Mylan reported a fall in revenue for first-quarter on Wednesday but upped its full year …
Mylan NV (NASDAQ:MYL) shares should be rising. Morgan Stanley upgraded Mylan stock just a few days ago, calling it the best pick among the domestic generic drugmakers. And, just this week Mylan announced it had launched an …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Shares of Mylan N.V. (NASDAQ: MYL) jumped on Tuesday after a key analyst came forward in favor of this pharmaceutical giant. This stock has been through the ringer over the past couple of years, but by the looks of it, Mylan could be …
It has. The recent investor-day event helped the company toot its own horn to be sure, still, MYL stock has been strangely stuck in neutral in recent days. It’s a curious situation that defies the news Mylan has been dishing out that’s been …